APLM Apollomics Inc.

Nasdaq N/A


$ 23.90 $ -5.21 (-18.48 %)    

Friday, 24-Oct-2025 17:28:34 EDT
QQQ $ 617.40 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.26 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.50 $ -1.27 (-0.34 %)
$ 23
$ 25.05
$ 22.28 x 300
$ 24.81 x 50
$ 22.64 - $ 26.96
$ 3.66 - $ 42.12
13,841
na
25.38M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

 apollomics-fy24-eps-5280-up-from-23199-yoy

Apollomics (NASDAQ:APLM) reported quarterly losses of $(52.80) per share. This is a 77.24 percent increase over losses of $(231...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION